Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer tests lower vaccine doses in trials for children
06:11am, Saturday, 19'th Nov 2022
Pfizer is moving into the later stages of clinical trials for testing its Covid-19 vaccine in children under the age of 11. CNBC's Meg Tirrell reports.
Pfizer developing a pill to treat Covid
04:56am, Saturday, 19'th Nov 2022
CNBC's Meg Tirrell reports that Pfizer is going full-speed ahead to develop a pill that will treat Covid in its early stages.
Biden administration to buy 500 million Pfizer vaccines for donation
02:16am, Saturday, 19'th Nov 2022
CNBC's Meg Tirrell joins 'Closing Bell' to discuss the Biden administration's plans to buy 500 million Pfizer vaccines to donate to low-income countries that have little access to vaccines.
Pfizer Inc. (PFE) 4th Annual Wolfe Research Healthcare Conference (Transcript)
01:10pm, Friday, 18'th Nov 2022
Pfizer Inc. (NYSE:PFE ) 4th Annual Wolfe Research Healthcare Conference Call November 18, 2022 8:45 AM ET Company Participants Dave Denton - Chief Financial Officer and Executive Vice President Chris
Pfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of data
10:52am, Friday, 18'th Nov 2022
A fresh analysis of data on the immune response generated by the bivalent COVID-19 booster showed strong results against the newer omicron sublineages, Pfizer and German partner BioNTech said Friday.
Pfizer says omicron booster is better against new subvariants like BQ.1.1 than old shots
10:51am, Friday, 18'th Nov 2022
Pfizer said the booster triggered more antibodies against omicron BQ.1.1, BA.4.6, BA.2.75.2 and XBB.1 in adults older than 55 compared to the original vaccines.
New Pfizer-BioNTech Covid Vaccine Is More Effective Than The Original, Study Shows
10:35am, Friday, 18'th Nov 2022
An estimated 68% of Americans are fully vaccinated.
Pfizer and BioNTech say bivalent booster increases neutralizing antibodies against new omicron variants
06:59am, Friday, 18'th Nov 2022
Pfizer Inc. PFE, +0.58% and German partner BioNTech SE BNTX, +0.82% said Friday a new analysis of data reviewing the immune response created by the omicron BA.4/BA.5 adapted bivalent COVID vaccine sho
Pfizer, BioNTech Take Next Step Toward A Pan-Covid Vaccine — But Is The Demand There?
11:07am, Thursday, 17'th Nov 2022
Pfizer and BioNTech said Thursday they've started testing a next-generation Covid shot, but the vaccine stocks tumbled. The post Pfizer, BioNTech Take Next Step Toward A Pan-Covid Vaccine — But Is T
Pfizer A Top 25 Dividend Giant With 3.29% Yield
08:36am, Wednesday, 16'th Nov 2022
Pfizer has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a staggering $34.47B worth of stock held by ETFs, and above-average ''DividendRank'' statistics including a strong 3.29% yield
Four Healthcare Stocks To Watch This Week
08:18am, Wednesday, 16'th Nov 2022
Healthcare has long been a wise investment, as the industry consistently grows yearly. Some analysts believe that trend will continue.
Moderna Surges On New Omicron Data, Pulling Pfizer, BioNTech Along For The Ride
02:42pm, Monday, 14'th Nov 2022
Moderna stock popped Monday after the company said its bivalent Covid booster led to a 15-fold jump in omicron-blocking antibodies. The post Moderna Surges On New Omicron Data, Pulling Pfizer, BioNTec
3 Stocks With Dividends of 3% or More to Buy on the Dip
09:30am, Monday, 14'th Nov 2022
Three underpriced healthcare stocks provide an opportunity.
The 7 Most Undervalued Value Stocks to Buy Now
10:50pm, Saturday, 12'th Nov 2022
Value stocks have seen a resurgence in demand during 2022. Rising interest rates increase borrowing costs, making speculative behavior less appealing.
Is This Blue-Chip Dividend Stock a Buy?
10:23am, Friday, 11'th Nov 2022
Shares of this pharmaceutical stock have surged higher in 2022.
